Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
São Paulo med. j ; 131(2): 141-141, abr. 2013.
Article in English | LILACS-Express | LILACS | ID: lil-671675

ABSTRACT

BACKGROUND Hot flushes are common in women with a history of breast cancer. Hormonal therapies are known to reduce these symptoms but are not recommended in women with a history of breast cancer due to their potential adverse effects. The efficacy of non-hormonal therapies is still uncertain. OBJECTIVE To assess the efficacy of non-hormonal therapies in reducing hot flushes in women with a history of breast cancer. METHODS Search methods: We searched the Cochrane Breast Cancer Group Specialised Register, CENTRAL (The Cochrane Library), Medline, Embase, Lilacs, CINAHL, PsycINFO (August 2008) and WHO ICTRP Search Portal. We handsearched reference lists of reviews and included articles, reviewed conference proceedings and contacted experts. Selection criteria: Randomized controlled trials (RCTs) comparing non-hormonal therapies with placebo or no therapy for reducing hot flushes in women with a history of breast cancer. Data collection and analysis: Two authors independently selected potentially relevant studies, decided upon their inclusion and extracted data on participant characteristics, interventions, outcomes and the risk of bias of included studies. MAIN RESULTS Sixteen RCTs met our inclusion criteria. We included six studies on selective serotonin (SSRI) and serotonin-norepinephrine (SNRI) reuptake inhibitors, two on clonidine, one on gabapentin, two each on relaxation therapy and homeopathy, and one each on vitamin E, magnetic devices and acupuncture. The risk of bias of most studies was rated as low or moderate. Data on continuous outcomes were presented inconsistently among studies, which precluded the possibility of pooling the results. Three pharmacological treatments (SSRIs and SNRIs, clonidine and gabapentin) reduced the number and severity of hot flushes. One study assessing vitamin E did not show any beneficial effect. One ...

2.
Rev. méd. Chile ; 139(12): 1611-1616, dic. 2011. ilus
Article in Spanish | LILACS | ID: lil-627598

ABSTRACT

Biomedical Informatics is a new discipline that arose from the need to incorporate information technologies to the generation, storage, distribution and analysis of information in the domain of biomedical sciences. This discipline comprises basic biomedical informatics, and public health informatics. The development of the discipline in Chile has been modest and most projects have originated from the interest of individual people or institutions, without a systematic and coordinated national development. Considering the unique features of health care system of our country, research in the area of biomedical informatics is becoming an imperative.


Subject(s)
Humans , Medical Informatics/education , Chile
3.
Rev. méd. Chile ; 132(2): 256-259, feb. 2004. ilus, tab
Article in Spanish | LILACS | ID: lil-361504

ABSTRACT

Introduction: Oxidized LDL is thought to play an important part in the pathogenesis of atherosclerosis. Observational studies have associated alpha tocopherol (vitamin E), beta carotene, or both, with reductions in cardiovascular events, but not clinical trials. We did a meta-analysis to assess the effect of these compounds on long term cardiovascular mortality and morbidity. Methods: We analyzed seven randomized trials of vitamin E treatment and, separately, eight of beta carotene treatment; all trials included 1000 or more patients. The dose range for vitamin E was 50-800 IU, and for beta carotene was 15-50 mg. Follow-up ranged from 1.4 to 12.0 years. Findings: The vitamin E trials involved a total of 81788 patients and the beta carotene trials 138113 in the all cause mortality analyses. Vitamin E did not provide benefit in mortality compared with control treatment (11.3 vs 11.1 percent, odds ratio 1.02 [95 percent CI 0.98-1.06] p=0.42) or significantly decrease risk of cardiovascular death (6.0 vs 6.0 percent, p=0.86) or cerebrovascular accident (3.6 vs 3.5 percent, p=0.31). Beta carotene led to a small but significant increase in all cause mortality (7.4 vs 7.0 percent, 1.07 [1.02-1.11] p=0.003) and with a slight increase in cardiovascular death (3.4 vs 3.1 percent, 1.1 [1.03-1.17] p=0.003). No significant heterogeneity was noted for any analysis. Interpretation: The lack of a salutary effect was seen consistently for various doses of vitamins in diverse populations. Our results, combined with the lack of mechanistic data for efficacy of vitamin E, do not support the routine use of vitamin E.


Subject(s)
Antioxidants/therapeutic use , Vitamin E/therapeutic use , Antioxidants , Cardiovascular Diseases/therapy , Vitamin E , beta Carotene/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL